Abstract：Objective: To investigate the effect of Huachansu capsule combined with NX chemotherapy on serum-related tumor markers and median survival in patients with advanced breast cancer. Methods: From February 2014 to April 2016, 92 patients with advanced breast cancer were enrolled in our hospital. As the random number table method, they were divided into control group (n=46) and experimental group (n=46). The control group was given NX chemotherapy (capecitabine + vinorelbine). On this basis, the experimental group was given Huachansu capsule for 2 consecutive treatments. The therapeutic effects, adverse reactions, and Karnofsky functional status score (KPS) were observed in the two groups. Serum tumor markers [saccharide antigen 15-3 (CA153), carcinoembryonic antigen (CEA)] and metastasis-invasive indicators before and after treatment [matrix metal] Protease-9 (MMP-9), vascular endothelial growth factor (VEGF)], and two-year follow-up of the two groups of patients, the median survival (OS), median progression-free survival (PFS) were compared. Results: There was no significant difference between the RR group and the control group (P>0.05). The difference of serum CA153, CEA, VEGF and MMP-9 between the two groups was more significant than that of the control group (P<0.05); Both groups of adverse reactions were grade II-III. The incidence of thrombocytopenia, anemia, and neutropenia in the experimental group was lower than that in the control group (P<0.05). The improvement rate of KPS score in the experimental group was higher than that in the control group (P<0.05); After treatment During the 2-year follow-up, the median OS and median PFS in the experimental group were greater than those in the control group (P<0.05). Conclusion: Huachansu capsule combined with NX chemotherapy in the treatment of patients with advanced breast cancer is effective, can reduce adverse reactions, reduce serum CA153, CEA, VEGF, MMP-9 levels, improve quality of life, and prolong the survival of patients
陈浩. 华蟾素胶囊联合NX化疗方案对晚期乳腺癌患者血清肿瘤标志物及中位生存期的影响[J]. 河北医学, 2019, 25(3): 533-536.
CHEN Hao. Effect of Huachansu Capsule Combined with NX Chemotherapy on Serum Related Tumor Markers and Median Survival in Patients with Advanced Breast Cancer. HeBei Med, 2019, 25(3): 533-536.
2019, Vol. 25 
冀公网安备13080202000677号